Search

Search Constraints

You searched for: Author/Creator Hokari, Ryota

Search Results

1. 1, 4‐Dihydroxy‐2‐naphthoic acid from Propionibacterium freudenreichii reduces inflammation in interleukin‐10‐deficient mice with colitis by suppressing macrophage‐derived proinflammatory cytokines. Issue 3 (25th June 2013)

2. Acesulfame potassium induces dysbiosis and intestinal injury with enhanced lymphocyte migration to intestinal mucosa. Issue 11 (21st August 2021)

3. Active and passive smoking and risk of ulcerative colitis: A case–control study in Japan. Issue 4 (13th December 2021)

4. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. (July 2022)

5. Amelioration of colitis through blocking lymphocytes entry to Peyer's patches by sphingosine‐1‐phosphate lyase inhibitor. Issue 9 (12th March 2018)

6. Angiopoietin‐like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells. Issue 5 (7th April 2021)

7. Association of Dietary Fatty Acid Intake With the Development of Ulcerative Colitis: A Multicenter Case-Control Study in Japan. Issue 5 (15th April 2021)

8. Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis. Issue 11 (12th July 2019)

10. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort. Issue 10 (October 2021)